SCP
KURA icon

Sender Company & Partners’s Kura Oncology KURA Stock Holding History

Sender Company & Partners’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,359
Closed -$285K – 75
2021
Q4 		$285K Buy
+20,359
New +$330K 0.15% 83

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Sender Company & Partners's KURA Position: Q1 2022 in Review

Sender Company & Partners sold out of Kura Oncology (KURA) in Q1 2022, closing a stake of 20,359 shares — an estimated $285K sold.

Sender Company & Partners first reported a position in KURA in Q4 2021 and held it in 1 quarter. The position peaked at $285K in Q4 2021. 152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

  • Sender Company & Partners reported no remaining Kura Oncology position as of Q1 2022 after selling out during the quarter.
  • Sender Company & Partners sold 20,359 Kura Oncology shares in Q1 2022, an estimated $285K.
  • Sender Company & Partners first reported a position in Kura Oncology in Q4 2021 and held it in 1 quarter.
  • Sender Company & Partners's Kura Oncology position peaked at $285K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Sender Company & Partners's 13F filing for Q1 2022, filed 17 May 2022.